- Home
- CPRX vs VIRT Comparison
CPRX vs VIRT Comparison
Compare CPRX & VIRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPRX
- VIRT
- Stock Information
- Founded
- CPRX 2002
- VIRT 2008
- Country
- CPRX United States
- VIRT United States
- Employees
- CPRX N/A
- VIRT N/A
- Industry
- CPRX Biotechnology: Pharmaceutical Preparations
- VIRT Investment Bankers/Brokers/Service
- Sector
- CPRX Health Care
- VIRT Finance
- Exchange
- CPRX Nasdaq
- VIRT Nasdaq
- Market Cap
- CPRX 2.6B
- VIRT 2.8B
- IPO Year
- CPRX 2006
- VIRT 2015
- Fundamental
- Price
- CPRX $20.82
- VIRT $32.22
- Analyst Decision
- CPRX Strong Buy
- VIRT Hold
- Analyst Count
- CPRX 5
- VIRT 8
- Target Price
- CPRX $33.20
- VIRT $40.88
- AVG Volume (30 Days)
- CPRX 1.6M
- VIRT 1.1M
- Earning Date
- CPRX 11-05-2025
- VIRT 10-23-2025
- Dividend Yield
- CPRX N/A
- VIRT 2.99%
- EPS Growth
- CPRX 183.96
- VIRT 122.21
- EPS
- CPRX 1.65
- VIRT 4.40
- Revenue
- CPRX $558,499,000.00
- VIRT $2,617,631,000.00
- Revenue This Year
- CPRX $16.51
- VIRT N/A
- Revenue Next Year
- CPRX $9.58
- VIRT N/A
- P/E Ratio
- CPRX $12.64
- VIRT $7.31
- Revenue Growth
- CPRX 28.55
- VIRT 42.88
- 52 Week Low
- CPRX $19.05
- VIRT $29.82
- 52 Week High
- CPRX $26.58
- VIRT $45.77
- Technical
- Relative Strength Index (RSI)
- CPRX 58.08
- VIRT 19.75
- Support Level
- CPRX $19.05
- VIRT $34.89
- Resistance Level
- CPRX $21.07
- VIRT $35.99
- Average True Range (ATR)
- CPRX 0.59
- VIRT 0.76
- MACD
- CPRX 0.16
- VIRT -0.10
- Stochastic Oscillator
- CPRX 60.27
- VIRT 6.22
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).
About VIRT Virtu Financial Inc.
Virtu Financial Inc is a financial firm that leverages technology to deliver liquidity to the world-wide markets and transparent trading solutions to its clients. The company's operating segment includes Market Making; and Execution Services. The non-operating segment of the company includes the Corporate segment. The company generates maximum revenue from the market-making segment. The Market Making segment principally consists of market-making in the cash, futures, and options markets across equities, options, fixed income, currencies, and commodities. Geographically, it derives a majority of its revenue from the United States and also has a presence in Ireland and Other Countries.